Jonathan Bard
- Cellular and Molecular Neuroscience top 0.5%
- Genetic Neurodegenerative Diseases 12
- Neuropeptides and Animal Physiology 10
- Neurotransmitter Receptor Influence on Behavior 7
- Molecular Biology top 5%
- Receptor Mechanisms and Signaling 18
- Mitochondrial Function and Pathology 10
- Urology top 2%
-
- Computational Drug Discovery Methods 8
-
- Alzheimer's disease research and treatments 11
-
- Neurological disorders and treatments 9
- Co-authors
- Richard L. WeinshankTheresa A. BranchekNika AdhamMary W. WalkerT. A. BranchekP J VaysseMichael S. MalamasRebecca Cowling
- Journals
- Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Biological Chemistry (5 papers)Journal of Nuclear Medicine (4 papers)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
Jonathan Bard
52 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Cellular and Molecular Neuroscience 1.9k
- Endocrine and Autonomic Systems 312
- Molecular Biology 2.2k
- Urology 171
- Computational Theory and Mathematics 318
Countries citing papers authored by Jonathan Bard
This map shows the geographic impact of Jonathan Bard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Bard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Bard more than expected).
Fields of papers citing papers by Jonathan Bard
This network shows the impact of papers produced by Jonathan Bard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Bard. The network helps show where Jonathan Bard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jonathan Bard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 8 | |
| 7 | 2022 | 15 | |
| 8 | 2016 | 14 | |
| 9 | 2014 | 70 | |
| 10 | 2011 | 24 | |
| 11 | 2010 | 27 | |
| 12 | 2009 | 38 | |
| 13 | 1998 | 47 | |
| 14 | 1998 | 41 | |
| 15 | 1998 | 222 | |
| 16 | 1997 | 33 | |
| 17 | 1997 | 40 | |
| 18 | Pharmacological characterization of the recombinant human 5-HT-7 receptor subtype coupled to adenylate cyclase stimulation in a clonal cell line | 1995 | 3 |
| 19 | 1995 | 323 | |
| 20 | 1994 | 86 |
About Jonathan Bard
Jonathan Bard is a scholar working on Cellular and Molecular Neuroscience, Microbiology, Molecular Biology, Neurology and Computational Theory and Mathematics, having authored 56 papers that have together received 3.7k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (18 papers), Genetic Neurodegenerative Diseases (12 papers), Alzheimer's disease research and treatments (11 papers), Mitochondrial Function and Pathology (10 papers), Neuropeptides and Animal Physiology (10 papers), Neurological disorders and treatments (9 papers), Computational Drug Discovery Methods (8 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.9k citations), Endocrine and Autonomic Systems (312 citations), Molecular Biology (2.2k citations), Urology (171 citations) and Computational Theory and Mathematics (318 citations). Jonathan Bard has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Richard L. Weinshank, Theresa A. Branchek, Nika Adham, Mary W. Walker, T. A. Branchek, P J Vaysse, Michael S. Malamas, Rebecca Cowling, J M Zgombick and Margaret M. Durkin. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Journal of Nuclear Medicine, Alzheimer s & Dementia and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.